The J&J vaccine is the third authorised in the United States, following ones from Pfizer/BioNTech and Moderna, both of which require two doses. Shipments to vaccination sites are expected to begin on Sunday or Monday.
US virus cases may stick at 70,000 a day, fears Fauci
The case baseline at 70,000 a day, needs to fall further before the US can confidently resume normal activities, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
China rolls out its single dose Covid-19 vaccine
China has given conditional approval for a single dose vaccine, touted to be a rival to Johnson & Johnson’s one-jab shot cleared by the US drug regulator on Sunday. Ad5-nCoV was rolled out on Friday.
New Zealand calls 7-day lockdown in largest city
New Zealand Prime Minister Jacinda Ardern announced a lockdown for its largest city Auckland while authorities investigate a new case of Covid. Auckland will enter the lockdown from 6 am on Sunday.
UAE cases drop 22% from late January peak
Covid cases in the United Arab Emirates have fallen by more than a fifth from a late January peak, a slower rate of decline than in Israel and the United Kingdom. Cases started rising again at the end-2020.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)